2025-07-25 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the provided data, formatted as a concise report with numerical summaries and brief interpretations.

**Report: UnitedHealth Group Inc (UNH) Analysis**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** UNH
*   **Company Overview:** UnitedHealth Group Inc is a diversified healthcare company providing a wide range of healthcare products and services.
*   **UNH Cumulative Return:** 10.49%
*   **VOO Cumulative Return:** 98.88%
*   **Disparity:**
    *   **Absolute Difference:** -88.39%
    *   **Range:** Max: 55.3, Min: -85.2, Current: -84.0
    *   **Relative Disparity:** 0.9

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) based on the cumulative returns as of the latest data point. The relative disparity indicates that UNH's performance is near the lower end of its historical range compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha  | Beta  | Cap(B) |
|------------|---------|-------|--------|-------|--------|
| 2015-2017  | 65.0%   | 56.6% | 36.0%  | 0.0   | 200.0  |
| 2016-2018  | 52.0%   | 63.7% | 34.0%  | 0.0   | 226.0  |
| 2017-2019  | 38.0%   | 63.7% | 9.0%   | 0.3   | 266.7  |
| 2018-2020  | -21.0%  | 63.7% | -40.0% | 0.4   | 318.1  |
| 2019-2021  | 36.0%   | 61.0% | -13.0% | 0.4   | 455.5  |
| 2020-2022  | 28.0%   | 66.9% | 26.0%  | 0.4   | 480.9  |
| 2021-2023  | 33.0%   | 67.5% | 15.0%  | 0.4   | 477.6  |
| 2022-2024  | -31.0%  | 68.6% | -57.0% | 0.3   | 458.9  |
| 2023-2025  | -66.0%  | 75.7% | -116.0%| 0.2   | 252.7  |

**Analysis:**  The table presents rolling 3-year performance metrics. CAGR (Compound Annual Growth Rate) has varied significantly, with recent periods showing negative growth. Maximum Drawdown (MDD) has generally increased, indicating higher risk.  Alpha has been volatile, turning sharply negative in recent periods, suggesting underperformance relative to a benchmark. Beta is consistently low, indicating low systematic risk. Cap(B) represents market capitalization in billions.

**2. Recent Price Action:**

*   **Last Price:** 278.58
*   **Previous Close:** 292.51
*   **Change:** -4.76%
*   **5-day Moving Average:** 284.20
*   **20-day Moving Average:** 299.06
*   **60-day Moving Average:** 317.31

**Analysis:** The stock price has recently declined, closing below its 5-day, 20-day, and 60-day moving averages, suggesting a potential short-term downtrend. The significant price drop from the previous close (-4.76%) confirms a strong downside move.

**3. Indicators and Expected Return:**

*   **Market Risk Indicator (MRI):** 0.3274 (Low Risk)
*   **RSI:** 28.42 (Oversold)
*   **PPO:** -0.29
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **20-day Relative Disparity Change:** 0.9 (Positive - short-term increase)
*   **Expected Return:** 1114.9%

**Analysis:** The MRI suggests low market risk. RSI indicates an oversold condition, which *could* signal a potential for a rebound. The PPO is negative. The hybrid signal is 'Buy 80% of cash,' with a caution note. The recent increase in relative disparity suggests a short-term upward movement *relative to the S&P 500, despite the overall underperformance*. However, the dramatic price change needs careful consideration.The extremely high expected return (1114.9%) should be treated with significant skepticism, as it seems implausibly high and may be due to model errors.

**4. Recent News & Significant Events:**

*   **2025-07-21:** Major business developments, regulatory changes, or market events impacting UNH.
*   **2025-07-22:** Analyst discussions on UNH's recent performance in the context of industry and global economic factors.
*   **2025-07-23:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-24:** Market experts highlight risks and opportunities, advising monitoring of recent news and company announcements.

**Analysis:** Recent news indicates significant activity and volatility surrounding UNH, making careful monitoring of company announcements and market trends crucial.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출         |
|------------|-------|--------------|
| 2025-05-07 | 6.9   | 109.58 B$    |
| 2024-11-04 | 6.56  | 100.82 B$    |
| 2024-08-09 | 4.58  | 98.86 B$    |
| 2024-05-09 | -1.53 | 99.80 B$    |
| 2025-05-07 | -1.53 | 99.80 B$    |

**Analysis:** The data presents inconsistent dates in 2025-05-07. Revenue has generally been increasing, however, EPS(Earnings Per Share) has fluctuated, with negative EPS in the 2024-05-09 and 2025-05-07 quarters. The inconsistent dates makes the time-series analysis difficult.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $109.58B   | 21.70%        |
| 2024-12-31   | $100.81B   | 21.14%        |
| 2024-09-30   | $100.82B   | 22.84%        |
| 2024-06-30   | $98.86B    | 22.31%        |
| 2024-03-31   | $99.80B    | 23.05%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE     |
|--------------|------------|---------|
| 2025-03-31   | $95.04B    | 6.62%   |
| 2024-12-31   | $92.66B    | 5.98%   |
| 2024-09-30   | $94.53B    | 6.41%   |
| 2024-06-30   | $89.36B    | 4.72%   |
| 2024-03-31   | $86.69B    | -1.63%  |

**Analysis:**  Revenue has generally increased over the past year. Profit margins have been relatively stable. Equity has also grown, and ROE (Return on Equity) has been positive except for one quarter, indicating generally profitable use of shareholder equity.

**7. Overall Summary**

UNH has significantly underperformed the S&P 500 recently. Technical indicators suggest a potential short-term bounce, but the overall trend appears downward. Recent news events and the significant price drop highlight increased volatility. Earnings data shows fluctuating EPS despite generally increasing revenue. Financially, the company shows growth in revenue, equity, and generally positive ROE. The extremely high "expected return" should be treated with extreme caution.

**Recommendation:**

Given the recent underperformance, volatility, and mixed signals from technical indicators, a cautious approach is warranted. Investors should carefully monitor company announcements, industry trends, and news events. The "Buy" signal from the Hybrid model should be considered in light of the caution flag and the negative earnings data. The 1114.9% expected return is unrealistic and should be disregarded. A detailed fundamental analysis is recommended before making any investment decisions.
